EichorEICHOR
Study identifier: NCT06799637 Synced from ClinicalTrials.gov · August 03, 2026
● Recruiting

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

Condition: Advanced Solid Tumors · Pancreatic Carcinoma · Ovarian Cancer  ·  Sponsor: Evopoint Biosciences Inc.

PhasePhase 1/Phase 2
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is an open-label, dose escalation, multicenter, phase 1, first-in-human study of XNW28012 in subjects with advanced solid tumors who have failed current standard anti-tumor therapies or are intolerant to such therapies. The study consists of two parts: a dose escalation part and a dose expansion part.

This description comes directly from the study's public registry record.

Talk to the study team

Yingjie zhao Yingjie Zhao  ·  +86 15553136593  ·  yingjie.zhao@evopointbio.com

Ziwen Ke  ·  +86 15172466243  ·  ziwen.ke@evopointbio.com

Always discuss trial participation with your own doctor first.

Locations (24)

Second Affiliated Hospital of Anhui Medical UniversityHefei, Anhui, ChinaRecruiting
The First Affiliated Hospital of University of Science and Technology of ChinaHefei, Anhui, ChinaRecruiting
Beijing Friendship Hospital, Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
Peking Union Medical College HospitalBeijing, Beijing Municipality, ChinaRecruiting
Chongqing University Cancer HospitalChongqing, Chongqing Municipality, ChinaRecruiting
Fujian Provincial Cancer HospitalFuzhou, Fujian, ChinaRecruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangzhou, Guangdong, ChinaRecruiting
Affiliated Hospital of Guizhou Medical UniversityGuiyang, Guizhou, ChinaRecruiting
Affiliated Hospital of Hebei UniversityBaoding, Hebei, ChinaRecruiting
Affiliated Cancer Hospital of Harbin Medical UniversityHarbin, Heilongjiang, ChinaRecruiting
First Affiliated Hospital of Henan University of Science and TechnologyLuoyang, Henan, ChinaRecruiting
Hubei Cancer HospitalWuhan, Hubei, ChinaRecruiting

+ 12 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →